Paige AI

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai

http://paige.ai

51-200 employees

Growth Trajectory

Paige.AI's growth lies in expanding its AI applications across multiple cancer types, developing customized AI models, and licensing its AI technology. They are focusing on bringing cutting-edge technology to market efficiently, as evidenced by their reach in over 45 countries and partnerships with 800+ laboratory and medical institutions. The development of Paige Alba and expansion into various cancer suites indicate significant growth potential.

Technical Challenges

Development and validation of AI models for cancer diagnostics.

Ensuring privacy, security, and clinical excellence in AI model development.

Integrating AI-based diagnostics with existing pathology workflows and lab information systems.

Handling and processing large datasets of digitized pathology slides and genomic data.

Detecting phenotypic changes associated with genetic alterations in cancer.

Tech Stack

AIMachine LearningFoundation Models (Virchow, Virchow2, Virchow2G, Virchow2G Mini, PRISM)Computational PathologyImage AnalysisNext-Generation Sequencing Assay DataGoogle AnalyticsHubSpotGoogle Tag Manager

Team Size

Key Risks

Regulatory hurdles in bringing AI-based diagnostic tools to market.

Maintaining data privacy and security compliance, especially with GDPR.

Competition from traditional AI development methods and other AI-driven diagnostic companies.

Ensuring the accuracy and reliability of AI-based diagnoses to avoid misdiagnosis.

Opportunities

Licensing AI technology to other organizations for customized AI model development.

Expanding the PanCancer Suite to address multiple tissue types and rare cancers.

Further developing Paige Alba as a multimodal AI co-pilot for pathologists.

Capitalizing on the increasing need for precision medicine in cancer diagnostics.

Leveraging partnerships with laboratory and medical institutions to expand market reach.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes